Abstract:
본 발명은 항바이러스 활성을 갖는 새빨간검둥이 추출물을 유효성분으로 함유하는 조성물을 제공한다. 또한, 새빨간검둥이를 유기용매로 추출한 후 감압증류하여 추출물을 얻는 단계; 상기 단계에서 얻어진 유기용매 추출물을 용매의 극성의 차이를 이용하여 분획하여 분획추출물을 얻는 단계; 및 상기 단계에서 얻어진 분획추출물을 크로마토그래피로 분리 및 정제하는 단계;를 포함하는 폴리브로모카테콜의 분리방법을 제공한다. 본 발명에 의하면 인간 리노바이러스에 대한 억제능이 우수하며 천연물 유래이기 때문에 안전하고 독성이 적은 항바이러스 물질을 제공할 수 있다. 또한, 새빨간검둥이로부터 폴리브로모카테콜 화합물을 손쉽게 분리할 수 있어, 바이러스 질환에 대한 예방 및 치료제로 사용가능한 약학 조성물을 제공할 수 있다.
Abstract:
The present invention relates to a method for quantifying fatty oil using means IV, and more specifically, to a method for quantifying fatty oil in a living body using means IV. According to one embodiment of the present invention, liquid chromatography (Nanospace SI-2, Shiseido co. Ltd, Tokyo, Japan) with high performance using a sunfire C8 column is used to separate an analyte (triolein, diolein, and monoolein) from an extracted solution. [Reference numerals] (AA) Weight of oil(mg) converted to Sudan IV; (BB) Weight of oil(mg) analyzed to LC/MS; (CC) Sudan recovery rate/Oil recovery rate; (DD) Amount of injected oil(쨉L)
Abstract:
The present invention relates to a novel potassium organo-1H-1,2,3-triazole-4-yltrifluoroborate derivative and a manufacturing method thereof. The novel potassium organo-1H-1,2,3- triazole-4-yltrifluoroborate derivative according to the present invention can be usefully used in the manufacture of various kinds of organo 1,2,3-triazole through a general carbon-carbon coupling reaction utilizing a metallic catalyst such as Suzuki-Miyaura coupling, and can be applied to an organic combination reaction, an optical organic material manufacture, medicine production, a medical diagnosis material, a biocompatible material and a bioactive natural material. The manufacturing method for the potassium organo-1H-1,2,3-triazole-4-yltrifluoroborate derivative according to the present invention can manufacture the stable potassium organo-1H-1,2,3-triazole-4-yltrifluoroborate derivative with a single reaction. Accordingly, a manufacturing process is fast, convenient, efficient and economic.
Abstract:
PURPOSE: A simultaneous assay method of multiplex cytochrome P450 enzyme activity is provided to simultaneously measure the activity change of various cytochrome P450 enzymes and to study diseases related to the cytochrome P450 enzyme activity. CONSTITUTION: A simultaneous assay method of multiplex cytochrome P450 enzyme activity comprises: a step of simultaneously extracting steroid hormone metabolic products including male hormones, female hormones, corpus luteum hormones, sterol, and adrenal cortical hormones from urine; a step of re-extracting the extracts using an organic solvent and performing trimethyl silyl derivatization; and a step of measuring the concentration of steroid hormone biometabolic products in the urine by gas chromatography-mass spectrometer. [Reference numerals] (AA) Before dosing a drug; (BB) After dosing a drug;
Abstract:
PURPOSE: A high sensitive analyzing method of estrogen metabolites in urine and blood obtained from postmenopausal women is provided to verify the overall distribution of estrogen metabolism and to be used for overcoming diseases related to estrogen metabolism. CONSTITUTION: A high sensitive analyzing method of estrogen metabolites in urine and blood obtained from postmenopausal women includes the following steps: estrogen is simultaneously extracted from urine and blood obtained from postmenopausal women and is hydrolyzed; the hydrolyzed product is alkoxy carbonylated using C1-4 alkyl chloroformate, and the resultant product is re-extracted using an organic solvent to obtain a re-extract; and the re-extract is acyl-derivated, and the concentration of estrogen is measured in the acyl-derivated product using a gas chromatography-mass spectrometry. The organic solvent is one or the mixture of normal hexane, normal pentane, butyl methyl ether, and ethyl acetate.
Abstract:
PURPOSE: A method for simultaneously detecting nucleotides in blood plasma using a capillary electrophoresis-mass spectrometer is provided to effectively separate nine kinds of nucleotides from a blood plasma specimen by securing optimal analyzing conditions of the capillary electrophoresis-mass spectrometer. CONSTITUTION: A method for simultaneously detecting nucleotides in blood plasma includes the following: protein is removed from the blood plasma; the blood plasma without the protein passes through a micelle electrokinetically capillary chromatography column which is adjusted with a surfactant containing developing solvent; and the treated blood plasma is analyzed by a capillary electrophoresis-mass spectrometer. The protein is removed using 50-70% of an ethanol solution containing ethylene diamine tetraacetic acid(EDTA). The concentration of the EDTA is in a range between 1 and 5 mM. The surfactant is a cationic surfactant. The developing solvent is an ammonium acetate buffer solution. The concentration of the ammonium acetate buffer solution is in a range between 10 and 60 nM.
Abstract:
PURPOSE: A method for analyzing metabolic differentiation of hair samples based on quantitative steroid signature is provided to evaluate endocrine disease and biological changes related to steroid hormones. CONSTITUTION: A method for analyzing metabolic differentiation of hair samples includes the following: hair samples are decomposed based on ultrasound wave; steroid hormone biological metabolites including androgen, progesterone, sterol, and adrenocortical hormones are simultaneously extracted; steroid hormone is re-extracted from the metabolites using copolymer absorber; the re-extracted product is trimethylsilyl derivatizated; and the concentration of the metabolites is measured based on a gas chromatography-mass spectrometry.
Abstract:
PURPOSE: A method for simultaneously analyzing cholesterol, oxysterol, and bile acid in urine is provided to treat diseases and to prevent side effect. CONSTITUTION: A method for simultaneously detecting cholesterol, oxysterol, and bile acid in urine comprises a step of TMS(trimethylsilylation) derivatization of cholesterol, oxysterol, and bile acid contained in a urine sample. The simultaneous detection comprises: a process of treating enzyme to the urine sample for hydrolyzation; and a process of solvent extraction. The enzyme is beta-glucuronidase or arylsulfatase. They used solvent is a mixture solution of ethyl acetate and n-hexane, ethyl ether, or t-butyl methyl ether.
Abstract:
생체 뇨 시료 내 휘발성 유기 화합물(VOC) 대사체 농도 분석 방법으로서, 생체 뇨 시료로부터 휘발성 유기 화합물 대사체들을 추출하기 위하여 생체 뇨 시료의 pH를 산성으로 조절하고, 산성으로 조절된 생체 뇨 시료로부터 음이온 교환 카트리지를 이용하여 휘발성 유기 화합물 대사체들을 고체상 추출하는 방법을 제공한다. 본 발명의 일실시예에 따른 분석 방법을 이용함으로써, 적은 양의 생체 뇨 시료를 이용해서, 뇨 시료에서의 주요 VOC 대사체들의 농도를 동시에 정확하게 분석할 수 있다. 분석된 VOC 대사체들의 농도를 이용하여, 인체 내 VOC 유입에 따른 영향을 판별하기 위한 지표로 활용할 수 있다. 뇨 시료, 휘발성 유기 화합물, 대사체, 고체상 추출